Hutchison China Meditech (HCM) ORD USD0.10
4.00p
(1.45%)
- Add to watchlist
- Create an alert
- This stock can be held in a
4.00p
(1.45%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA,
SIPP or
Fund and Share Account
4.00p
(1.45%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA,
SIPP or
Fund and Share Account
273.50p
280.00p
5,600.00p
£1.81 bn
276.00p
261.00p
260.50p
n/a
11.75p (4.08%) Previous:
11.75p
115,380
n/a
3,000
Performance
| 1 week 1W | 7.8% | 1 year 1Y | 37.47% |
|---|---|---|---|
| 1 month 1M | 22.29% | 2 years 2Y | 39.45% |
| 3 months 3M | 24.39% | 3 years 3Y | 49.25% |
| 6 months 6M | 42.74% | 5 years 5Y | 138.6% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Fundamental data
| Year ending: | 31/12/2018 | 31/12/2017 |
|---|---|---|
| Revenue ($m) | 214.11 | 241.20 |
| Profit before tax ($m) | (86.66) | (53.54) |
| Adjusted EPS (¢): | (11.30) | (4.30) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: US dollar
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
To buy shares in , you'll need to have an account. Try our handy filter to explore the different options.
Ready to take your first step?
To invest in , you'll need to open an account.
Try our handy filter to find which one suits you best.
Important Documents
There are no documents available for this stock.
Broker forecasts
Broker recommendations for this stock are not available.
-
Hutchison China Meditech expands collaboration with Innovent
10 October 2019 15:45
-
Hutchison Chi-Med initiates latest study of HMPL-523
4 October 2019 15:21
-
Hutchison China MediTech launches trial for autoimmune disorder treatment
23 August 2019 11:25
-
Grant of share options under share option scheme
10 October 2019 10:22
-
Innovent and Chi-Med Expand Global Collaboration
10 October 2019 09:00
-
Chi-Med Phase I/Ib Trial of HMPL-523 in Lymphoma
4 October 2019 07:11
| Time / date Time | Buy / sell Type | Volume | Price | Value |
|---|
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled ‘N/A’.
Annual & interim reports
Annual & interim reports are not available for this stock.
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA,
SIPP or
Fund and Share Account
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.